Water narrow

Our Recent Publications

  1. Prevention, diagnosis, and management of midurethral mesh sling complications.
    Hengel AR, Carlson KV, Baverstock RJ.
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S135-S140

  2. Pelvic organ prolapse: A primer for urologists.
    Bureau M, Carlson KV.
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S125-S130.

  3. The management of mixed urinary incontinence in women.
    Welk B, Baverstock RJ.
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S121-S124.

  4. Medicolegal basics and update on transvaginal mesh in Canada.
    Hengel B, Welk B, Baverstock RJ.
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S108-S111.

  5. Canadian Urological Association position statement on the use of transvaginal mesh.
    Welk B, Carlson KV, Baverstock RJ, Steele SS, Bailly GG, Hickling DR.
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S105-S107.

  6. Female stress urinary incontinence: What's old is new again?
    Welk B, Carlson KV
    Can Urol Assoc J. 2017 Jun;11(6Suppl2):S103.

  7. Case distribution and complications of mid-urethral sling surgery in a Canadian city before and after the Health Canada advisory on pelvic floor mesh.
    Carlson K, Baverstock R, Civitarese A, Crump RT.
    Int Urogynecol J. 2017 May 25.

  8. Incidence of Children At Risk for Obstructive Sleep Apnea Undergoing Common Day Surgery Procedures.
    Holmes EM, Singh HH, Kirk VG, Brindle M, Luntley J, Weber BA, Yunker WK.
    J Pediatr Surg. 2017 May 28.

  9. OnabotulinumtoxinA for the treatment of idiopathic overactive bladder is effective and safe for repeated use.
    Carlson K, Civitarese A, Baverstock R.
    Can Urol Assoc J. 2017 11(5): E179-83.

  10. SPINK1 Overexpression in Localized Prostate Cancer: a Rare Event Inversely Associated with ERG Expression and Exclusive of Homozygous PTEN Deletion.
    Huang KC, Evans A, Donnelly B, Bismar TA.
    Pathol Oncol Res. 2017 Apr;23(2): 399-407.

  11. Robot-assisted Level II-III Inferior Vena Cava Tumor Thrombectomy: Step-by-Step Technique and 1-Year Outcomes.
    Metcalfe C, Chopra S, Simone G, de Castro Abreu AL, Nabhani J, Ferriero M, Bove AM, Sotelo R, Aron M, Desai MM, Gallucci M, Gill IS.
    Eur Urol. 2017 Aug;72(2): 267-274.

  12. Tubulovillous adenoma in the bladder in a dual pancreas-kidney transplant patient.
    Remondini T, Van Zyl S, Bismar T, Yilmaz, Hyndman ME.
    J Endourol Case Rep. 2017 Feb 1;3(1): 17-20.

  13. The Calcium-Dependent Switch Helix of L-Plastin Regulates Actin Bundling.
    Ishida H, Jensen K, Woodman A, Hyndman ME, Vogel H.
    Sci Rep. 2017 Feb 1;7: 40662.

  14. Urine and serum metabolomics analyses may distinguish between stages of renal cell carcinoma.
    Falegan O, Ball M, Shaykhutdinov R, Hollenberg M, Pieroraio P, Vogel H, Allaf M, Hyndman ME.
    Metabolites. 2017 Feb 3;7(1).

  15. Anticancer activities of bovine and human lactoferricin-derived peptides.
    Arias M, Hilchie AL, Haney EF, Hancock REW, Bolscher JGM, Hyndman ME, Vogel HJ.
    Biochem Cell Biol. 2017 Feb;95(1): 91-98.

  16. Eruption of Blood: AVM of the penile urethra.
    Baverstock R, White J.
    Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E32-E34.

  17. Global Gleason Grade Groups in prostate cancer: Concordance of biopsy and radical prostatectomy grades and predictors of upgrade and downgrade.
    Athanazio D, Gotto G, Shea-Budgell M, Yilmaz A, Trpkov K.
    Histopathology. 2017 Jun; 70(7): 1098-1106.

  18. Dysfunctional Voiding.
    Carlson K, Andrews M, Baverstock R.
    AUA Update Series 2017.

  19. Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification.
    Ghai S, Eure G, Fradet V, Hyndman ME, McGrath T, Wodlinger B, Pavlovich CP.
    J Urol. 2016 196: 2.

  20. Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma.
    Lawson KA, Mostafa AA, Shi ZQ, Spurrell J, Chen W, Kawakami J, Gratton K, Thakur S, Morris DG.
    Clin Cancer Res. 2016 1;22: 5839-5850.

  21. A clinical perspective on electronically collecting patient-reported outcomes at the point-of-care for overactive bladder.
    Desantis D, Baverstock RJ, Civitarese A, Crump RT, Carlson KV.
    Can Urol Assoc J. 2016 10(11-12): E359-366.

  22. Low compliance with guidelines for re-staging in high-grade T1 bladder cancer and the potential impact on patient outcomes in the province of Alberta.
    Gotto GT, Shea-Budgell MA, Ruether JD.
    Can Urol Assoc J. 2016 10(1-2): 33-38.

  23. Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA).
    Kassouf W et al.
    Can Urol Assoc J. 2016 10(1-2): E46-80.

  24. The use of intra-detrusor onabotulinumtoxinA in patients with myasthenia gravis.
    Wright I, Civitarese A, Baverstock R.
    Can Urol Assoc J. 2016 10(5-6): E184-5.

  25. Well-trained staff is the key to the success of urodynamic testing.
    Baverstock R.
    Can Urol Assoc J. 2016 10(5-6): 191.

  26. Assessing guideline adherence: referral patterns of post-prostatectomy patients to radiation oncologists.
    Taggar A, Alghamdi M, Tilly D, Kostaras X, Kerba M , Hussain S, Gotto G, Sia M.
    Can Urol Assoc J. 2016 10(9-10): 314-8.

  27. A survey of patient expectations regarding sexual function following radical prostatectomy.
    Deveci S, Gotto GT, Alex B, O'Brien K, Mulhall JP.
    BJU Int. 2016 118(4): 341-5.

  28. Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer.
    Forbes CM, Rendon RA, Finelli A, Kapoor A, Moore RB, Breau RH, Lacombe L, Kawakami J, Drachenberg DE, Pautler SE, Jewett MM, Saarela O, Liu Z, Tanguay S, Black PC.
    Urol Oncol. 2016 34(11): 486.e17-486.e23.

  29. Initial Series of Four-Arm Robotic Completely Intracorporeal Ileal Ureter.
    Chopra S, Metcalfe C, Satkunasivam R, Nagaraj S, Becker C, de Castro Abreu AL, Azhar RA, Gill I, Desai M, Aron M, Berger A.
    J Endourol. 2016 Apr: 395-99.

  30. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG, Patel P, Saarela O, Liu Z, Kapoor A, Finelli A, Tanguay S, Rendon R, Moore R, Black PC, Lacombe L, Breau RH, Kawakami J, Drachenberg DE.
    Urology. 2016 Aug;94: 154-60.

  31. Priapism as the Presenting Complaint in Fatal Group A Streptococcal Induced Disseminated Intravascular Coagulation.
    Baverstock R, Carey C.
    CJEM. 2016 Dec 19:1-3.

  32. Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.
    Wang T, Abou-Ouf H, Hegazy SA, Alshalalfa M, Stoletov K, Lewis J, Donnelly B, Bismar TA.
    J Mol Med (Berl). 2016 Dec;94(12): 1411-1422.

  33. The Impact of Transtomal Rigid Endoscopy in Continent Cutaneous Urinary Diversions.
    Metcalfe C, Loh-Doyle J, Chopra S, Abreu AL, Satkunasivam R, Azhar R, Simma-Chiang V, Dunn M.
    Urology. 2016 Jan: 60-3.

  34. Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education.
    Bernhard JC, Isotani S, Matsugasumi T, Duddalwar V, Hung AJ, Suer E, Baco E, Satkunasivam R, Djaladat H, Metcalfe C, Hu B, Wong K, Park D, Nguyen M, Hwang D, Bazargani ST, de Castro Abreu AL, Aron M, Ukimura O, Gill IS.
    World J Urol. 2016 Mar: 337-45.

  35. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
    Huang KC, Bégin LR, Palanisamy N, Donnelly B, Bismar TA.
    Urol Oncol. 2016 May;34(5): 235.e1-10.

  36. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
    Mason R, Kapoor A, Liu Z, Saarela O, Tanguay S, Jewett M, Finelli A, Lacombe L, Kawakami J, Moore R, Morash C, Black P,
    Rendon RA.
    Urol Oncol. 2016 Nov;34(11): 486.e1-486.e7.

  37. An audit of referral and treatment patterns of high-risk prostate cancer patients in Alberta.
    Alghamdi M, Taggar A, Tilly D, Kerba M, Kostaras X, Gotto G, Sia M.
    Can Urol Assoc J. 2016 Nov-Dec;10(11-12): 410-415.

  38. Urinothorax: An Unusual Cause of Pleural Effusion in a Pediatric Patient.
    Gerdung C, Anselmo M
    Respiratory Medicine Case Reports Journal. 2016 Oct.

  39. Sex-related Differences in Emergency Department Renal Colic Management: Females Have Fewer Computed Tomography Scans but Similar Outcomes.
    Innes GD, Scheuermeyer FX, Law MR, McRae AD, Weber BA, Boyda HN, Lonergan K, Andruchow JE.
    Acad Emerg Med. 2016 Oct;23(10): 1153-1160.

  40. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
    Box A, Alshalalfa M, Hegazy SA, Donnelly B, Bismar TA.
    Tumour Biol. 2016 Sep;37(9): 12287-12299.

  41. Incidental finding of a small cell renal carcinoma.
    Remondini T, Van Zyl S, Bismar T, Hyndman ME.
    Can Urol Assoc J. 2016.

Twitter  Facebook